N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
This study has been withdrawn prior to enrollment.
(No funding was available for the cost of the IV N-acetylcysteine (NAC).)
OHSU Knight Cancer Institute
Information provided by (Responsible Party):
Edward Neuwelt, OHSU Knight Cancer Institute
First received: June 3, 2010
Last updated: April 19, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||December 2014|
|Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|